| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |